Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Takahiko, Taniguchi"'
Autor:
Shohei Fukuda, Yumiko Nakase, Kazuhide Imagaki, Kanako Kondo, Takahiko Taniguchi, Osamu Uchikawa
Publikováno v:
ACS Omega, Vol 9, Iss 11, Pp 13440-13446 (2024)
Externí odkaz:
https://doaj.org/article/b6b6a3c5ee7d42b48b8f8908d76f1aae
Autor:
Kosuke TERANISHI, Yumiko MISHIMA, Takahiko TANIGUCHI, Takashi FUJII, Senshu NONAKA, Takayuki KITAMURA, Akihide KONDO, Hidenori OISHI
Publikováno v:
Neurologia Medico-Chirurgica, Vol 62, Iss 10, Pp 451-457 (2022)
As of January 2021, the Surpass Streamline (SS) is the most recently approved flow diverter in Japan. A total of 28 Japanese patients, including 9 clinical trial patients, with 28 large or giant unruptured internal carotid artery (ICA) aneurysms, und
Externí odkaz:
https://doaj.org/article/debec58894b84d9bbfadb54c348fae4c
Autor:
Takahiko TANIGUCHI, Kenji YATOMI, Kazumoto SUZUKI, Kohsuke TERANISHI, Hidenori OISHI, Akihide KONDO
Publikováno v:
Surgery for Cerebral Stroke. 51:56-61
Autor:
Takahiko Taniguchi, Kazumoto Suzuki, Kenji Yatomi, Kohsuke Teranishi, Akihide Kondo, Hidenori Oishi
Publikováno v:
Japanese Journal of Neurosurgery. 31:588-593
Autor:
Kazuo Imai, Kaku Tamura, Tomomi Tanigaki, Mari Takizawa, Eiko Nakayama, Takahiko Taniguchi, Misako Okamoto, Yasumasa Nishiyama, Norihito Tarumoto, Kotaro Mitsutake, Takashi Murakami, Shigefumi Maesaki, Takuya Maeda
Publikováno v:
Frontiers in Microbiology, Vol 9 (2018)
Introduction: Whole genome sequencing (WGS) of influenza viruses is important for preparing vaccines and coping with newly emerging viruses. However, WGS is difficult to perform using conventional next-generation sequencers in developing countries, w
Externí odkaz:
https://doaj.org/article/12d031765cc84dc89886b39bcd72155f
Autor:
Naoki Otani, Takahiko Taniguchi, Terushige Toyooka, Satoru Takeuchi, Kojiro Wada, Masataka Miyama
Publikováno v:
Journal of Neuroendovascular Therapy. 15:32-37
Autor:
Akina Harada, Kazunori Suzuki, Naomi Kamiguchi, Maki Miyamoto, Kimio Tohyama, Kosuke Nakashima, Takahiko Taniguchi, Haruhide Kimura
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0122197 (2015)
Phosphodiesterase 10A (PDE10A) inhibition is a novel and promising approach for the treatment of central nervous system disorders such as schizophrenia and Huntington's disease. A novel PDE10A inhibitor, TAK-063 [1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl
Externí odkaz:
https://doaj.org/article/68f3374951714c6daf7aaec04f3b8474
Publikováno v:
Organic Letters. 21:7254-7257
The direct monofluorination of N-protected pyridone derivatives has been developed using a stable electrophilic fluorinating reagent, N-fluorobenzenesulfonimide (NFSI). Interestingly, the fluorine atom is regioselectively introduced at the position o
Autor:
Takahiko Taniguchi
Publikováno v:
Journal of Synthetic Organic Chemistry, Japan. 80:91-91
Autor:
Takahiko Taniguchi, Yuki Ito, Haruka Imada, Masato Nakashima, Hiroki Iwashita, Noriko Suzuki, Eri Shiraishi, Maki Miyamoto
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 365:179-188
The pathophysiology of schizophrenia has been associated with glutamatergic dysfunction. Modulation of the glutamatergic signaling pathway, including N-methyl-d-aspartate (NMDA) receptors, can provide a new therapeutic target for schizophrenia. Phosp